AtriCure Inc (ATRC)
35.68
-0.35
(-0.97%)
USD |
NASDAQ |
Nov 21, 16:00
35.68
0.00 (0.00%)
After-Hours: 20:00
AtriCure Enterprise Value: 1.671B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.671B |
| November 20, 2024 | 1.688B |
| November 19, 2024 | 1.703B |
| November 18, 2024 | 1.624B |
| November 15, 2024 | 1.639B |
| November 14, 2024 | 1.653B |
| November 13, 2024 | 1.696B |
| November 12, 2024 | 1.717B |
| November 11, 2024 | 1.794B |
| November 08, 2024 | 1.757B |
| November 07, 2024 | 1.753B |
| November 06, 2024 | 1.766B |
| November 05, 2024 | 1.661B |
| November 04, 2024 | 1.573B |
| November 01, 2024 | 1.565B |
| October 31, 2024 | 1.549B |
| October 30, 2024 | 1.630B |
| October 29, 2024 | 1.366B |
| October 28, 2024 | 1.333B |
| October 25, 2024 | 1.293B |
| October 24, 2024 | 1.330B |
| October 23, 2024 | 1.338B |
| October 22, 2024 | 1.327B |
| October 21, 2024 | 1.323B |
| October 18, 2024 | 1.335B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.324B |
| October 16, 2024 | 1.353B |
| October 15, 2024 | 1.326B |
| October 14, 2024 | 1.277B |
| October 11, 2024 | 1.289B |
| October 10, 2024 | 1.250B |
| October 09, 2024 | 1.249B |
| October 08, 2024 | 1.263B |
| October 07, 2024 | 1.251B |
| October 04, 2024 | 1.278B |
| October 03, 2024 | 1.269B |
| October 02, 2024 | 1.282B |
| October 01, 2024 | 1.287B |
| September 30, 2024 | 1.298B |
| September 27, 2024 | 1.320B |
| September 26, 2024 | 1.332B |
| September 25, 2024 | 1.340B |
| September 24, 2024 | 1.384B |
| September 23, 2024 | 1.363B |
| September 20, 2024 | 1.361B |
| September 19, 2024 | 1.351B |
| September 18, 2024 | 1.311B |
| September 17, 2024 | 1.315B |
| September 16, 2024 | 1.277B |
| September 13, 2024 | 1.322B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
916.78M
Minimum
Jun 17 2024
3.944B
Maximum
Nov 05 2021
2.062B
Average
1.911B
Median
Oct 03 2023
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.853M |
| Revenue (Quarterly) | 115.91M |
| Total Expenses (Quarterly) | 123.32M |
| EPS Diluted (Quarterly) | -0.17 |
| Gross Profit Margin (Quarterly) | 74.88% |
| Profit Margin (Quarterly) | -6.78% |
| Earnings Yield | -2.33% |
| Normalized Earnings Yield | -2.262 |